AEMD - Aethlon Medical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Aethlon Medical, Inc.

9365 Granite Ridge Drive
Suite 100
San Diego, CA 92123
United States

IndustryMedical Devices
Full Time Employees6

Key Executives

NameTitlePayExercisedYear Born
Dr. Timothy C. RodellInterim CEO & Director392.24kN/A1951
Mr. James B. FrakesCFO, Sr. VP of Fin. & Sec.255.83kN/A1957
Mr. James A. JoyceConsultant393.25kN/A1962
Mr. Sunil SawhneyHead of Clinical StudiesN/AN/AN/A
Dr. Richard H. TullisConsultantN/AN/A1945
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Aethlon Medical, Inc., a medical technology company, focuses on addressing unmet needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. The company is based in San Diego, California.

Corporate Governance

Aethlon Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.